WuXi Biologics Weighs On Hong Kong, Regulators Encourage Buybacks - Forbes

Retrieved on: 2023-12-04 17:43:23

Tags for this article:

Hang Seng Index

Futures contract

WuXi Biologics

Exchange-traded funds

Draft:KraneShares

Stock market crashes

Click the tags to see associated articles and topics

WuXi Biologics Weighs On Hong Kong, Regulators Encourage Buybacks - Forbes. View article details on HISWAI: https://www.forbes.com/sites/brendanahern/2023/12/04/wuxi-biologics-weighs-on-hong-kong-regulators-encourage-buybacks/

Excerpt

Sentiment in the biotechnology industry is at an historic low and that is a global issue, not just a China issue. On Sunday, the China Securities ...

Article found on: www.forbes.com

View Original Article